Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lymphoma 4Small Cell Lung Carcinoma 2Multiple Myeloma 2Hematologic Neoplasms 2Neutropenia 1Lymphoma, Non-Hodgkin 1Advanced Pancreatic Cancer 1

Interventions

X-Rays 4anlotinib 3Standard of Care 3Radiosurgery 3Psychiatric Rehabilitation 3Early Intervention, Educational 3Drug Therapy 3Counseling 3pegylated granulocyte colony-stimulating factor 2Therapeutics 2Nicotine 2Exercise 2Cisplatin 2Carboplatin 2Bronchoalveolar Lavage 2Blood Specimen Collection 2toripalimab 1irinotecan sucrosofate 1iodixanol 1durvalumab 1chiauranib 1apatinib 1Varenicline 1Triage 1Trastuzumab 1Tomography, X-Ray Computed 1Tobacco Use Cessation Devices 1Taxes 1Surveys and Questionnaires 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Small Cell Lung Carcinoma × pegylated granulocyte colony-stimulating factor × Clear all
NCT04171986 2019-11-21

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
93 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03776604 2018-12-19

PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
61 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡